June 9 (UPI) A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study reports. Doctors favor treatment with continuous positive ...

But patients would rather treat their sleep apnea with tirzepatide (Zepbound), a GLP-1 weight-loss drug, researchers found. "The results highlight a need for real-world comparative effectiveness ...

But patients with obesity would rather use Zepbound to ease their apnea ...

Sleep Apnea Treatment Clash: Doctors prefer CPAP, but obese patients lean towards Zepbound. Explore this growing healthcare debate. MONDAY, June 9, 2025 (HealthDay News) — A clash is brewing between ...